Results 151 to 160 of about 25,650 (245)
ABSTRACT Introduction Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome with high mortality in adults. Diagnosis remains challenging due to nonspecific clinical features and overlap with sepsis, malignancy, and other inflammatory conditions. Data on HLH in underserved populations are limited. Methods We performed
Safia Ansari +5 more
wiley +1 more source
NaCl and urea modulate CD8+ T cell survival, renal accumulation, and response to BK virus. [PDF]
Falahat P +12 more
europepmc +1 more source
A Snapshot of the UK Blood Donor Plasma Virome: A Retrospective Cross‐Sectional Cohort Study
ABSTRACT Estimates of population prevalence and genetic diversity of bloodborne viruses in healthy humans are essential to support population‐scale monitoring for transfusion transmission risk. In the UK and globally, blood donations are routinely screened for a limited number of high‐consequence pathogens, but the full composition of the plasma virome
Kai Kean +12 more
wiley +1 more source
BK Virus Infection and Risk Factors in Kidney Transplant Recipients. [PDF]
Akcay OF +7 more
europepmc +1 more source
CGM Accuracy in a Fragmented Regulatory Landscape: A Commentary on Harmonisation and Recent Evidence
Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 7665-7671, September 2026.
Tadej Battelino +13 more
wiley +1 more source
Rhizospheric Microbes and Nanoparticles Synergize to Enhance Plant Immune Responses
Nanobiotics integrate engineered nanoparticles with beneficial rhizosphere microbes to synergistically enhance plant immunity, nutrient acquisition, and stress resilience. Multi‐omics and AI‐driven approaches enable precision design, accelerating sustainable, climate‐smart agriculture, and resilient crop production. ABSTRACT Sustainable crop production
Mohammad Nazrul Islam Bhuiyan +3 more
wiley +1 more source
Digital spatial profiling reveals the molecular signatures of BK virus infection in renal transplant recipients. [PDF]
He L +8 more
europepmc +1 more source
ABSTRACT Interindividual variability (IIV) in drug response complicates both fixed‐dose design and individualized therapy. Understanding how pharmacokinetic (PK) and pharmacodynamic (PD) processes jointly shape this variability is essential, particularly in combination therapy, where multiple interacting pathways influence outcomes. This study employed
Kuteesa R. Bisaso +3 more
wiley +1 more source

